NCT05994690View on ClinicalTrials.gov

CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

905

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

March 31, 2031

Study Completion Date

December 31, 2035

Conditions
Acute Myeloid Leukemia in Children
Interventions
DRUG

Standard Intervention Rc

3 consolidation courses (HAM + HA3E + FLA)

DRUG

Investigational Intervention Rc

2 consolidation courses (HAM + FLA)

DRUG

Standard Intervention Ri

No addition of GO to first induction course

DRUG

Investigational Intervention Ri

Addition of GO to first induction course

Trial Locations (1)

3584 CS

RECRUITING

Princess Máxima Center for pediatric oncology, Utrecht

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Princess Maxima Center for Pediatric Oncology

OTHER